Company Monitoring Page for Acadia

latest headlines for company on cafepharma

3 Plausible Buyout Scenarios Within Biotech
Seeking Alpha
Tue, 07/5/16 - 10:20 am
Tags:
biotech, Acadia, AstraZeneca, Allergan, Biogen, Teva Pharmaceutical, Biomarin, Incyte, Ironwood, Medivation, Pfizer, Relypsa, Synergy Pharmaceuticals, M&A
Pfizer, Biogen May Eye Acadia for Takeover
Bidness, ETC
Fri, 05/20/16 - 10:27 am
Tags:
Pfizer, Biogen, Acadia, M&A
U.S. approves first drug for psychosis linked to Parkinson's
Yahoo/Reuters
Sat, 04/30/16 - 10:42 am
Tags:
Parkinson's Disease Psychosis, FDA, Acadia, Nuplazid
Acadia: Approval Likely For Parkinson's Disease Psychosis Drug
Seeking Alpha
Wed, 04/13/16 - 11:56 am
Tags:
Acadia, Parkinson's Disease Psychosis, pimavanserin
Top 6 Biopharma Movers of the Past Week
24/7 Wall St
Mon, 04/4/16 - 07:56 am
Tags:
Genocea Biosciences, OPKO Health, ContraVir, Inovio, Acadia, Apricus Biosciences
This Could Be the Next Big Pharma Buyout
Motley Fool
Sun, 04/3/16 - 10:56 am
Tags:
Big Pharma, M&A, JNJ, Geron, Acadia, Jazz Pharmaceuticals, Bluebird Bio, Kite Pharma
Why Biogen Should Acquire ACADIA Pharmaceuticals
Bidness, ETC
Thu, 03/31/16 - 10:06 am
Tags:
Biogen, Acadia, M&A, Parkinson's Disease Psychosis, Nuplazid
FDA advisers back first drug intended to treat psychotic symptoms of Parkinson's disease
Yahoo/AP
Tue, 03/29/16 - 10:24 pm
Tags:
FDA, Parkinson's Disease Psychosis, Acadia, advisory panels, pimavanserin
It could reduce hallucinations, but at what cost? New Parkinson’s drug raises questions
Stat
Tue, 03/29/16 - 11:09 am
Tags:
Parkinson's Disease Psychosis, Nuplazid, Acadia
FDA's internal review of Acadia's Parkinson's drug raises safety, benefit concerns
Fierce Biotech
Sat, 03/26/16 - 12:41 pm
Tags:
FDA, Acadia, Parkinson's Disease Psychosis, Nuplazid
FDA staff backs Acadia's drug to treat psychosis associated with Parkinson's disease
Yahoo/Reuters
Fri, 03/25/16 - 09:37 am
Tags:
FDA, Acadia, Parkinson's Disease Psychosis, Nuplazid
5 Key FDA Decisions Expected in March
24/7 Wall St
Mon, 03/14/16 - 10:02 am
Tags:
FDA, Rayaldee, OPKO Health, Nuplazid, Acadia, abaloparatide, Radius Health, pegvaliase, Biomarin, ALD403, Alder Biopharmaceuticals
3 Upcoming FDA Decisions We're Most Excited About
Motley Fool
Sat, 02/13/16 - 09:25 am
Tags:
FDA, Acadia, Intercept Pharma, Clovis Oncology, Nuplazid, OCA, rociletinib
Should AbbVie, Inc. Buy Acadia Pharmaceuticals to Help Fight Parkinson's Disease?
Motley Fool
Wed, 04/8/15 - 10:46 am
Tags:
AbbVie, Acadia, Parkinson's Disease, Nuplazid
This Exciting Biotech Isn't Built to Last
Motley Fool
Thu, 03/19/15 - 11:10 am
Tags:
Acadia
Acadia Drug Is Delayed Again as CEO Announces Retirement
TheStreet.com
Wed, 03/11/15 - 08:28 pm
Tags:
Acadia, Nuplazid, Parkinson's Disease Psychosis
Acadia Surges as Canceled Events Lead to Deal Speculation
Bloomberg
Wed, 03/11/15 - 10:44 am
Tags:
Acadia, M&A
The Coming Boom In Brain Medicines
Forbes
Wed, 02/11/15 - 09:33 am
Tags:
Yumanity Therapeutics, SAGE Therapeutics, Acadia, Naurex, brain research
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
TheStreet.com
Fri, 01/9/15 - 09:17 am
Tags:
Celgene, Gilead Sciences, Express Scripts, Biogen Idec, Amicus Therapeutics, NPS Pharmaceuticals, Sanofi, Acadia, Orexigen, Pharmacyclics, Vertex Pharmaceuticals
Acadia surges after nabbing 'breakthrough' title for late-stage Parkinson's drug
Fierce Biotech
Tue, 09/2/14 - 11:19 am
Tags:
Parkinson's Disease, Acadia, pimavanserin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.